Skip to main content
NeuronFeed

Isomorphic Labs · Series B

London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug

Amount

$2.1B

Round

Series B

Valuation

—

Announced

May 2026

Investors

Lead investor

Thrive Capital

Participating investors

GV (Google Ventures) Temasek CapitalG Alphabet MGX UK Sovereign AI Fund

Notes

funding refresh

📎 Source

Other Isomorphic Labs rounds

Date Round Amount
May 2024 Series B $2.1B Details →
— Series A $600M Details →